Treatment Compliance of Patients Diagnosed With Chronic Obstructive Pulmonary Disease And Their Quality of Life After Follow-up: Evaluation Via Telemedicine
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Ankara Etlik City Hospital
- Enrollment
- 74
- Locations
- 1
- Primary Endpoint
- Inhaler adherence
Overview
Brief Summary
The Covid-19 pandemic has disrupted the follow-up and treatment processes for patients, and telemedicine has emerged as an important alternative method. Our aim was to test compare COPD Assessment Test (CAT) scores, inhaler treatment techniques and adherence between telemedicine-mediated healthcare and healthcare provided face-to-face.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Screening
- Masking
- None
Eligibility Criteria
- Ages
- 40 Years to 90 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients who were diagnosed with COPD according to Global Initiative for Obstructive Lung Disease (GOLD)
- •GOLD spirometric grade 3-4
- •At least one hospital admission in the past year
- •Acceptable score on the Mini-Mental State Examination
- •Residing in Ankara
- •Patient or caregiver must understand the process and be able to provide clear information
- •Medical records and laboratory test results must be accessible to healthcare professionals
- •Patient must have access to prescribed medications
- •Comorbidities outside of the lungs are included
Exclusion Criteria
- •Patients diagnosed with asthma
- •Patients with lung cancer
- •Patients with combined pulmonary fibrosis and emphysema
- •Patients with active infections such as pneumonia or COVID-19
- •Patients being followed for COPD without spirometry
- •Patients with low cognitive function as determined by the Mini-Mental State Examination
- •Patients who do not consent to participate in the study
- •Patients lacking adequate social support
- •Patients with COPD grade 1-2
- •Patients with no hospital admissions in the past year
Outcomes
Primary Outcomes
Inhaler adherence
Time Frame: 3 months
At the end of 3 months, inhaler adherence was compared. A 6-item Inhaler Adherence Scale (IAS) was used to evaluate inhaler treatment compliance. If the patient answered "yes" to even one of the items, they were deemed non-compliant. The questions: ''During the last 3 months; * have you at times been careless about using your inhaler or nebulizer?, * have you ever forgotten to use your inhaler or nebulizer? * have you ever stopped using your inhaler because you felt better? * have you ever stopped using your inhaler or nebulizer because you felt worse? * have you ever used your inhaler or nebulizer less than the doctor prescribed because you felt better? * have you ever used your inhaler or nebulizer more than the doctor prescribed because you felt you were having an attack?''.
Secondary Outcomes
- COPD Assesment Test (CAT) score(3 months)
Investigators
Zeynep Sena Doğan
MD
Gazi University